← Leaderboards
David G Russell
Texas A&M University System
$39,223,482
Attributed
$41,084,955
Total exposure
24
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,084,955 · 24
By mechanism
R01$32,001,536 · 13
U19$4,790,049 · 2
R21$1,375,982 · 3
R33$1,245,828 · 1
S10$862,340 · 2
R56$462,345 · 1
Top collaborators
- Henry Charles Mwandumba5 shared
- Digby Francis Warner2 shared
- Lubbe Joachim Wiesner2 shared
Most similar at Texas A&M University System
Same institution · by research overlap
- John D. McKinney$3,428,234
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageMycobacterium TuberculosisCellsInfectionTuberculosisProgramsEnvironmentPhenotypeBacteriaIn VivoImmuneLungPathway InteractionsPathogenBaseReporterResponseMediatingAlveolar MacrophagesIn VitroMalawiSiteLaboratory MousePhagocytes
Grant awards (102)
Minimizing in vivo Drug Tolerance induction in tuberculosis.$861,173
U19 · FY2025 · AI · contact PI
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.$482,843
R01 · FY2025 · AI · contact PI
Minimizing in vivo Drug Tolerance induction in tuberculosis.$808,212
U19 · FY2024 · AI · contact PI
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.$676,923
R01 · FY2024 · AI · contact PI
Lung immune function in human TB infection and its perturbation by HIV-1.$653,018
R01 · FY2024 · AI · contact PI
Minimizing in vivo Drug Tolerance induction in tuberculosis.$699,638
U19 · FY2023 · AI · contact PI
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.$695,223
R01 · FY2023 · AI · contact PI
Lung immune function in human TB infection and its perturbation by HIV-1.$656,738
R01 · FY2023 · AI · contact PI
Lung immune function in human TB infection and its perturbation by HIV-1.$658,518
R01 · FY2022 · AI · contact PI
Minimizing in vivo Drug Tolerance induction in tuberculosis.$624,587
U19 · FY2022 · AI · contact PI
Are HIV-1-Infected Alveolar Macrophages Productive Sites of Viral Persistence?$404,874
R33 · FY2022 · AI · contact PI
BSL3 Flow Sorter for Human Pathogens of Global Significance$362,340
S10 · FY2022 · OD · contact PI
Lung immune function in human TB infection and its perturbation by HIV-1.$659,438
R01 · FY2021 · AI · contact PI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains$647,888
R01 · FY2021 · AI · contact PI
Minimizing in vivo Drug Tolerance induction in tuberculosis.$608,113
U19 · FY2021 · AI · contact PI
Are HIV-1-Infected Alveolar Macrophages Productive Sites of Viral Persistence?$413,352
R33 · FY2021 · AI · contact PI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains$707,313
R01 · FY2020 · AI · contact PI
Lung immune function in human TB infection and its perturbation by HIV-1.$676,988
R01 · FY2020 · AI · contact PI
Are HIV-1-Infected Alveolar Macrophages Productive Sites of Viral Persistence?$427,602
R33 · FY2020 · AI · contact PI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains$695,858
R01 · FY2019 · AI · contact PI
How does HIV lead to increased susceptibility to tuberculosis?$546,571
R01 · FY2019 · AI · contact PI
Are HIV-1-Infected Alveolar Macrophages Productive Sites of Viral Persistence?$213,489
R21 · FY2019 · AI · contact PI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains$743,107
R01 · FY2018 · AI · contact PI
How does HIV lead to increased susceptibility to tuberculosis?$551,971
R01 · FY2018 · AI · contact PI
Are HIV-1-Infected Alveolar Macrophages Productive Sites of Viral Persistence?$212,808
R21 · FY2018 · AI · contact PI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains$742,635
R01 · FY2017 · AI · contact PI
How does HIV lead to increased susceptibility to tuberculosis?$546,571
R01 · FY2017 · AI · contact PI
How does HIV lead to increased susceptibility to tuberculosis?$551,971
R01 · FY2016 · AI · contact PI
Do HIV-infected Alveolar Macrophages represent a cART-resistant Reservoir?$462,345
R56 · FY2016 · AI · contact PI
The role of monocytes in the pathology of severe malaria.$218,294
U19 · FY2016 · AI · contact PI
Drug permeation and activity in Mycobacterium tuberculosis infected macrophages$153,439
R21 · FY2016 · AI
How does HIV lead to increased susceptibility to tuberculosis?$586,997
R01 · FY2015 · AI · contact PI
Environmental Cues and Responses in Tuberculosis$436,534
R01 · FY2015 · AI · contact PI
The Role of the Granuloma in M. Tuberculosis Infections$426,261
R01 · FY2015 · HL · contact PI
The role of monocytes in the pathology of severe malaria.$270,783
U19 · FY2015 · AI · contact PI
Drug permeation and activity in Mycobacterium tuberculosis infected macrophages$160,246
R21 · FY2015 · AI
Restoration of alveolar macrophage function in HIV patients: A clinical study.$476,373
R01 · FY2014 · HL · contact PI
Environmental Cues and Responses in Tuberculosis$436,534
R01 · FY2014 · AI · contact PI
The Role of the Granuloma in M. Tuberculosis Infections$424,098
R01 · FY2014 · HL · contact PI
The role of monocytes in the pathology of severe malaria.$225,957
U19 · FY2014 · AI · contact PI
Restoration of alveolar macrophage function in HIV patients: A clinical study.$460,613
R01 · FY2013 · HL · contact PI
The Role of the Granuloma in M. Tuberculosis Infections$411,185
R01 · FY2013 · HL · contact PI
Environmental Cues and Responses in Tuberculosis$410,343
R01 · FY2013 · AI · contact PI
Development of a Cell-Based HTS for Inhibitors of Inflammatory Macrophages$357,230
R01 · FY2013 · AI · contact PI
The role of monocytes in the pathology of severe malaria.$241,442
U19 · FY2013 · AI · contact PI
Restoration of alveolar macrophage function in HIV patients: A clinical study.$479,534
R01 · FY2012 · HL · contact PI
The Role of the Granuloma in M. Tuberculosis Infections$443,530
R01 · FY2012 · HL · contact PI
Environmental Cues and Responses in Tuberculosis$436,534
R01 · FY2012 · AI · contact PI
Development of a Cell-Based HTS for Inhibitors of Inflammatory Macrophages$380,176
R01 · FY2012 · AI · contact PI
The role of monocytes in the pathology of severe malaria.$231,850
U19 · FY2012 · AI · contact PI
Restoration of alveolar macrophage function in HIV patients: A clinical study.$479,534
R01 · FY2011 · HL · contact PI
Environmental Cues and Responses in Tuberculosis$449,865
R01 · FY2011 · AI · contact PI
Development of a Cell-Based HTS for Inhibitors of Inflammatory Macrophages$380,317
R01 · FY2011 · AI · contact PI
Development of a cell-based HTS for compounds with activity against tuberculosis$266,495
R01 · FY2011 · AI · contact PI
Restoration of alveolar macrophage function in HIV patients: A clinical study.$534,527
R01 · FY2010 · HL · contact PI
The Role of The Granuloma in M. Tuberculosis Infections$409,863
R01 · FY2010 · HL · contact PI
Cell Biology of Mycobacterium Tuberculosis Infection$408,779
R01 · FY2010 · AI · contact PI
Enviromental cues and responses in tuberculosis$363,066
R01 · FY2010 · AI · contact PI
Development of a cell-based HTS for compounds with activity against tuberculosis$270,139
R01 · FY2010 · AI · contact PI
Cell Biology of Mycobacterium Tuberculosis Infection$408,779
R01 · FY2009 · AI · contact PI
Development of a Novel Strategy of Adjuvant Discovery$408,329
R01 · FY2009 · AI · contact PI
The Role of The Granuloma in M. Tuberculosis Infections$397,928
R01 · FY2009 · HL · contact PI
Enviromental cues and responses in tuberculosis$366,733
R01 · FY2009 · AI · contact PI
Development of a cell-based HTS for compounds with activity against tuberculosis$363,063
R01 · FY2009 · AI · contact PI
Development of a cell-based HTS for compounds with activity against tuberculosis$95,900
R01 · FY2009 · AI · contact PI
Development of a Novel Strategy of Adjuvant Discovery$396,434
R01 · FY2008 · AI · contact PI
The Role of The Granuloma in M. Tuberculosis Infections$386,333
R01 · FY2008 · HL · contact PI
Enviromental cues and responses in tuberculosis$366,137
R01 · FY2008 · AI · contact PI
Zeiss LSM510 Meta Confocal Microscope$500,000
S10 · FY2007 · RR · contact PI
Cell Biology of Mycobacterium tuberculosis Infection$481,064
R01 · FY2007 · AI · contact PI
Development of a Novel Strategy of Adjuvant Discovery$392,344
R01 · FY2007 · AI · contact PI
The Role of The Granuloma in M. Tuberculosis Infections$373,864
R01 · FY2007 · HL · contact PI
Environmental cues and responses in tuberculosis$372,621
R01 · FY2007 · AI · contact PI
Cell Biology of Mycobacterium tuberculosis Infection$481,002
R01 · FY2006 · AI · contact PI
Development of a Novel Strategy of Adjuvant Discovery$392,290
R01 · FY2006 · AI · contact PI
The Role of The Granuloma in M. Tuberculosis Infections$387,189
R01 · FY2006 · HL · contact PI
Enviromental cues and responses in tuberculosis$383,750
R01 · FY2006 · AI · contact PI
Cell Biology of Mycobacterium tuberculosis Infection$478,231
R01 · FY2005 · AI
Development of a Novel Strategy of Adjuvant Discovery$390,178
R01 · FY2005 · AI
THE ROLE OF THE GRANULOMA IN M. TUBERCULOSIS INFECTIONS$353,540
R01 · FY2005 · HL
Cell Biology of Mycobacterium tuberculosis Infection$464,302
R01 · FY2004 · AI
THE ROLE OF THE GRANULOMA IN M. TUBERCULOSIS INFECTIONS$353,662
R01 · FY2004 · HL
Metabolism of M. tuberculosis: New Targets for MDR TB$318,000
R21 · FY2004 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$209,982
R01 · FY2004 · AI
THE ROLE OF THE GRANULOMA IN M. TUBERCULOSIS INFECTIONS$353,782
R01 · FY2003 · HL
Metabolism of M. tuberculosis: New Targets for MDR TB$318,000
R21 · FY2003 · AI
Cell Biology of Mycobacterium tuberculosis Infection$225,390
R01 · FY2003 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$203,867
R01 · FY2003 · AI
THE ROLE OF THE GRANULOMA IN M. TUBERCULOSIS INFECTIONS$353,897
R01 · FY2002 · HL
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$197,928
R01 · FY2002 · AI
Fatty Acid Catabolism &the glyoxylate shunt in Mycobact$40,320
R03 · FY2002 · TW
Drug discovery for persistent tuberculosis$0
P01 · FY2002 · AI
THE ROLE OF THE GRANULOMA IN M. TUBERCULOSIS INFECTIONS$354,009
R01 · FY2001 · HL
FLAGELLAR POCKET OF LEISHMANIA$297,621
R01 · FY2001 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$192,163
R01 · FY2001 · AI
Fatty Acid Catabolism &the glyoxylate shunt in Mycobact$40,320
R03 · FY2001 · TW
Drug discovery for persistent tuberculosis$0
P01 · FY2001 · AI
FLAGELLAR POCKET OF LEISHMANIA$288,953
R01 · FY2000 · AI
Drug discovery for persistent tuberculosis$225,915
P01 · FY2000 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$116,700
R01 · FY2000 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP$91,470
R01 · FY2000 · AI
Fatty Acid Catabolism &the glyoxylate shunt in Mycobact$40,320
R03 · FY2000 · TW